| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/30/2004 | CA2518968A1 Drug composition with antimicrobial activity |
| 09/30/2004 | CA2518443A1 Naphthyridine derivatives as antibacterial agents |
| 09/30/2004 | CA2518227A1 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 09/29/2004 | EP1462449A1 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels |
| 09/29/2004 | EP1462443A1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1461614A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 09/29/2004 | EP1461610A2 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use |
| 09/29/2004 | EP1461450A1 T-bet compositions and methods of use thereof |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461441A1 Flavivirus vaccine delivery system |
| 09/29/2004 | EP1461422A1 Interleukin-2 gene transferred lymphokine activated killer cells |
| 09/29/2004 | EP1461361A1 Negatively charged polysaccharide derivable from aloe vera |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461357A2 Novel hev antigenic peptide and methods |
| 09/29/2004 | EP1461342A1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461333A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461326A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461319A1 Quinoline derivatives, synthesis method, and medicines containing said derivatives |
| 09/29/2004 | EP1461310A1 Bacterial enzyme inhibitors |
| 09/29/2004 | EP1461308A2 Bacterial enzyme inhibitors |
| 09/29/2004 | EP1461165A1 Metallic structures incorporating bioactive materials and methods for creating the same |
| 09/29/2004 | EP1461122A2 Treatment of genitourinary tract disorders |
| 09/29/2004 | EP1461092A1 Process for coating a surface of a stent |
| 09/29/2004 | EP1461084A2 Guanidinium transport reagents and conjugates |
| 09/29/2004 | EP1461080A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1461067A1 Compositions and method for treating hepatitis virus infection |
| 09/29/2004 | EP1461055A1 Anti-bacterial plant compositions |
| 09/29/2004 | EP1461054A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 09/29/2004 | EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/29/2004 | EP1461036A2 Bis hydrochloride monohydrate salt of rsv fusion inhibitor |
| 09/29/2004 | EP1461032A2 Use of tyrosine kinase inhibitors for promoting hair growth |
| 09/29/2004 | EP1461019A2 Bioadhesive drug delivery system with enhanced gastric retention |
| 09/29/2004 | EP1460999A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 09/29/2004 | EP1339502B1 Device for Coating an Object with an Active Ingredient and Method for Producing a Partial or Complete Active Ingredient Coating on and in Implants and Onplants as well as Use of or Product Obtained through such a Method |
| 09/29/2004 | EP1299350B1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 09/29/2004 | EP1289495B1 Process for the preparation of a sterile ointment containing acyclovir |
| 09/29/2004 | EP1210320B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1206267B1 Medicaments containing xenogenic oligo- or/and polyribonucleotides |
| 09/29/2004 | EP1202959B1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 09/29/2004 | EP1202957B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1200400B1 Substituted pyrrolidin-2,3,4-trion derivatives useful as nmda-receptor antagonists |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1169339B1 Macrocyclic peptides inhibiting the hepatitis c virus ns3 protease |
| 09/29/2004 | EP1090018B1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 09/29/2004 | EP1084147B1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 09/29/2004 | EP1059913B1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/29/2004 | EP1037664B1 Vaccines containing attenuated bacteria |
| 09/29/2004 | EP1028961B1 Pleuromutilin derivatives as antimicrobials |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP1015012A4 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 09/29/2004 | EP0989999B1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 09/29/2004 | EP0956045B1 Assembly-deficient herpesvirus vaccine |
| 09/29/2004 | CN1533442A Cimeric immunomodulatory compounds and methods of using the same |
| 09/29/2004 | CN1533434A Inflenza vaccine composition |
| 09/29/2004 | CN1533433A Method for virus propagation |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533397A 6-2'-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral acticity |
| 09/29/2004 | CN1533392A Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 09/29/2004 | CN1533390A Drugs containing triazaspiro [5,5] undecane derivatives as the active ingredient |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533285A Adjuvant combination formulations |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533279A Organo-phosphorous compounds for activating gamma/delta T-cells |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1533242A Foot and mouth disease virus vaccine |
| 09/29/2004 | CN1532535A Method for detecting compound having manoamine oxidase inhibiting activity |
| 09/29/2004 | CN1532292A Transcription active test |
| 09/29/2004 | CN1532289A Method for preparing N-end acetylation modified thymosin alpha with recombined E. coli |
| 09/29/2004 | CN1532285A Methanol yeast Pichia pastoris produce the augmenters of liver regeneration and its mutant. |
| 09/29/2004 | CN1532206A Active fragment of thymosin alphal and its polyethylene glycol derivatives |
| 09/29/2004 | CN1532196A Quinic compound containing quaternary ammonium group and its preparation and medicina use |
| 09/29/2004 | CN1532181A Intermediate for preparing benzo-oxazine derivative and its preparing method |
| 09/29/2004 | CN1531957A Medicine for treating tuberdulosis and lung disease and its preparing method |
| 09/29/2004 | CN1531933A Medicinal composition for treating hepatitis |
| 09/29/2004 | CN1531931A Method for improving solubility of clarithromycin |
| 09/29/2004 | CN1168827C Nucleotide specific to O-antigen of shigella boydii 7 |
| 09/29/2004 | CN1168735C New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 09/29/2004 | CN1168734C Novel erythromycin derivatives, method for preparing same, and use thereof as drug |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168503C Veterinarian virus kind biological product heat resistig freeze drying protective agent and its preparation technique |
| 09/29/2004 | CN1168502C Porcine circovirus and parvovirus vaccine |
| 09/29/2004 | CN1168500C Method for generating bi-RNA-virus from synthetic RNA transcripts |
| 09/29/2004 | CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 09/29/2004 | CN1168489C Skin-haemorrhoids-clearing ointmenta nd preparing method thereof |
| 09/29/2004 | CN1168488C Chinese medicinal preparation for treating pyretic stranguria |
| 09/29/2004 | CN1168478C Chinese herbal medicine for treating hepatitis A |
| 09/29/2004 | CN1168475C Chinese herbal medicine composition for treating pyloric spirobacterium infected gastropathy and its production process |
| 09/29/2004 | CN1168467C Medicine for treating syphilis |
| 09/29/2004 | CN1168449C Medicine against human papilloma virus |
| 09/29/2004 | CN1168447C Use of oxazolidinones for preparation of medicament for transdermal delivery |
| 09/28/2004 | US6797820 Succinate compounds, compositions and methods of use and preparation |
| 09/28/2004 | US6797811 Antibodies to chemokine receptor 88C |
| 09/28/2004 | US6797730 Peptide deformylase inhibitors |